Literature DB >> 33984274

Coevolution between bacterial CRISPR-Cas systems and their bacteriophages.

Bridget N J Watson1, Jurre A Steens2, Raymond H J Staals2, Edze R Westra3, Stineke van Houte4.   

Abstract

CRISPR-Cas systems provide bacteria and archaea with adaptive, heritable immunity against their viruses (bacteriophages and phages) and other parasitic genetic elements. CRISPR-Cas systems are highly diverse, and we are only beginning to understand their relative importance in phage defense. In this review, we will discuss when and why CRISPR-Cas immunity against phages evolves, and how this, in turn, selects for the evolution of immune evasion by phages. Finally, we will discuss our current understanding of if, and when, we observe coevolution between CRISPR-Cas systems and phages, and how this may be influenced by the mechanism of CRISPR-Cas immunity.
Copyright © 2021 Elsevier Inc. All rights reserved.

Keywords:  CRISPR-Cas; bacteriophages; coevolution; ecology; evolution

Year:  2021        PMID: 33984274     DOI: 10.1016/j.chom.2021.03.018

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   21.023


  9 in total

1.  Legionella pneumophila Cas2 Promotes the Expression of Small Heat Shock Protein C2 That Is Required for Thermal Tolerance and Optimal Intracellular Infection.

Authors:  Jackson A Campbell; Nicholas P Cianciotto
Journal:  Infect Immun       Date:  2022-09-08       Impact factor: 3.609

Review 2.  Understanding the Mechanisms That Drive Phage Resistance in Staphylococci to Prevent Phage Therapy Failure.

Authors:  Andrea Jurado; Lucía Fernández; Ana Rodríguez; Pilar García
Journal:  Viruses       Date:  2022-05-16       Impact factor: 5.818

3.  High viral abundance and low diversity are associated with increased CRISPR-Cas prevalence across microbial ecosystems.

Authors:  Sean Meaden; Ambarish Biswas; Ksenia Arkhipova; Sergio E Morales; Bas E Dutilh; Edze R Westra; Peter C Fineran
Journal:  Curr Biol       Date:  2021-11-09       Impact factor: 10.834

Review 4.  CRISPR/Cas12a-based technology: A powerful tool for biosensing in food safety.

Authors:  Zefeng Mao; Ruipeng Chen; Xiaojuan Wang; Zixuan Zhou; Yuan Peng; Shuang Li; Dianpeng Han; Sen Li; Yu Wang; Tie Han; Jun Liang; Shuyue Ren; Zhixian Gao
Journal:  Trends Food Sci Technol       Date:  2022-03-01       Impact factor: 12.563

5.  Structural basis of cyclic oligoadenylate binding to the transcription factor Csa3 outlines cross talk between type III and type I CRISPR systems.

Authors:  Pengjun Xia; Anirudha Dutta; Kushol Gupta; Mona Batish; Vijay Parashar
Journal:  J Biol Chem       Date:  2022-01-14       Impact factor: 5.157

Review 6.  Antibiotic Resistance and Mechanisms of Pathogenic Bacteria in Tubo-Ovarian Abscess.

Authors:  Huanna Tang; Hui Zhou; Runju Zhang
Journal:  Front Cell Infect Microbiol       Date:  2022-07-27       Impact factor: 6.073

7.  Epidemiological and evolutionary consequences of different types of CRISPR-Cas systems.

Authors:  Hélène Chabas; Viktor Müller; Sebastian Bonhoeffer; Roland R Regoes
Journal:  PLoS Comput Biol       Date:  2022-07-26       Impact factor: 4.779

8.  CRISPR-Cas12a-mediated DNA clamping triggers target-strand cleavage.

Authors:  Mohsin M Naqvi; Laura Lee; Oscar E Torres Montaguth; Fiona M Diffin; Mark D Szczelkun
Journal:  Nat Chem Biol       Date:  2022-07-14       Impact factor: 16.174

9.  Rethinking Protein Drug Design with Highly Accurate Structure Prediction of Anti-CRISPR Proteins.

Authors:  Ho-Min Park; Yunseol Park; Joris Vankerschaver; Arnout Van Messem; Wesley De Neve; Hyunjin Shim
Journal:  Pharmaceuticals (Basel)       Date:  2022-03-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.